We next tested the effect of knockdown of the most effective inhibitor of exon 7 inclusion, SRSF3, in multipotent neural stem cells generated from iPS cells derived from a type 1 SMA patient [48], [57], [58]. This evidence concerns the gene SRSF3 and spinal muscular atrophy, type 1.